Amicus Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Amicus Therapeutics, Inc.‘s stocks are currently a part of 205 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 300.20M shares of Amicus Therapeutics, Inc.. Compared to the previous quarter, the number fell by -0.36% or -1.08M shares fewer. As for the holding position changes, 30.73% (63) of current hedge fund investors increased the number of shares held, 39.51% (81) of current holders sold a part of the shares held, and 15.12% (31) closed the holdings completely. 23 hedge funds are new holders of Amicus Therapeutics, Inc. stock in Q1 2022, it is 11.22% of total holders.
Hedge funds holding Amicus Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 138 |
|---|---|
| Q3 2017 | 184 |
| Q4 2017 | 182 |
| Q1 2018 | 200 |
| Q2 2018 | 197 |
| Q3 2018 | 200 |
| Q4 2018 | 188 |
| Q1 2019 | 201 |
| Q2 2019 | 200 |
| Q3 2019 | 199 |
| Q4 2019 | 214 |
| Q1 2020 | 196 |
| Q2 2020 | 220 |
| Q3 2020 | 245 |
| Q4 2020 | 268 |
| Q1 2021 | 249 |
| Q2 2021 | 225 |
| Q3 2021 | 228 |
| Q4 2021 | 218 |
| Q1 2022 | 205 |
Hedge funds changes in Amicus Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 28 | 43 | 44 | 17 | 6 |
|---|---|---|---|---|---|
| Q3 2017 | 59 | 71 | 38 | 13 | 3 |
| Q4 2017 | 27 | 76 | 54 | 27 | -2 |
| Q1 2018 | 37 | 87 | 57 | 14 | 5 |
| Q2 2018 | 32 | 66 | 65 | 33 | 1 |
| Q3 2018 | 32 | 79 | 61 | 26 | 2 |
| Q4 2018 | 23 | 71 | 61 | 35 | -2 |
| Q1 2019 | 38 | 76 | 54 | 25 | 8 |
| Q2 2019 | 39 | 91 | 36 | 36 | -2 |
| Q3 2019 | 38 | 84 | 51 | 37 | -11 |
| Q4 2019 | 48 | 86 | 54 | 28 | -2 |
| Q1 2020 | 30 | 65 | 71 | 46 | -16 |
| Q2 2020 | 43 | 73 | 74 | 17 | 13 |
| Q3 2020 | 44 | 74 | 94 | 19 | 14 |
| Q4 2020 | 49 | 87 | 99 | 27 | 6 |
| Q1 2021 | 48 | 96 | 76 | 65 | -36 |
| Q2 2021 | 34 | 81 | 70 | 55 | -15 |
| Q3 2021 | 32 | 82 | 76 | 25 | 13 |
| Q4 2021 | 25 | 74 | 80 | 36 | 3 |
| Q1 2022 | 23 | 63 | 81 | 31 | 7 |
Hedge funds changes in Amicus Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 31,422,000 | 12,919,000 |
|---|---|---|
| Q3 2017 | 46,081,710,000 | 75,377,000 |
| Q4 2017 | 26,095,194,000 | 80,566,000 |
| Q1 2018 | 136,691,000 | 86,564,000 |
| Q2 2018 | 2,076,413,000 | 13,802,000 |
| Q3 2018 | 52,183,000 | 9,991,000 |
| Q4 2018 | 11,397,000 | 2,722,000 |
| Q1 2019 | 26,883,000 | 8,151,000 |
| Q2 2019 | 12,811,000 | 11,474,000 |
| Q3 2019 | 7,673,000 | 2,581,000 |
| Q4 2019 | 9,487,000 | 5,743,000 |
| Q1 2020 | 13,452,000 | 4,361,000 |
| Q2 2020 | 43,353,000 | 4,232,000 |
| Q3 2020 | 38,319,000 | 14,673,000 |
| Q4 2020 | 85,238,000 | 79,551,000 |
| Q1 2021 | 26,567,000 | 21,634,000 |
| Q2 2021 | 19,468,000 | 5,586,000 |
| Q3 2021 | 20,986,000 | 13,298,000 |
| Q4 2021 | 9,670,000 | 3,908,000 |
| Q1 2022 | 3,561,000 | 2,564,000 |